-
Track & Monitor
New![]()
Innovation in automotive: DC-DC converters
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the automotive industry’s DC-DC converters innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience in...
-
Product Insights
New![]()
Washington DC DGS Solar PV Park
Washington DC DGS Solar PV Park is a solar PV project located in Washington, United States. The project is owned by WGL Energy Systems Inc and was developed by Sol Systems LLC; WGL Energy Systems Inc. The project came online in 2018. Empower your strategies with our Washington DC DGS Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
New![]()
Net Present Value Model: DICE Therapeutics Inc’s DC-806
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Track & Monitor
New![]()
Electric vehicles in power: DC fast charging EVs
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the power industry’s DC fast charging EVs within Electric Vehicles innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Cervical Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Cervical Cancer Drug Details:DC-6001 is under development for the treatment of metastatic solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-05F01 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DC-05F01 in Solid Tumor Drug Details: DC-05F01 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Gastric Cancer Drug Details:DC-6001 is under development for the treatment of metastatic solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Solid Tumor Drug Details:DC-6001 is under development for the treatment of metastatic solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Glioblastoma Multiforme (GBM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Glioblastoma Multiforme (GBM) Drug Details:DC-6001 is under development for the treatment of metastatic solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Metastatic Colorectal Cancer Drug Details:DC-6001 is under development for the treatment of metastatic solid...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.